Novel anti-inflammatory mechanism of action of Lyprinol® in the AIA rat model

Progress in Nutrition

Volumn 10, Issue 3, 2008, Pages 146-152

  Halpern, Georges M ^a,b  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b NONE   (United States)

Author keywords

Adjuvant induced arthritis; Cytokines; Lyprinol ; Pain; Perna canaliculus; Proteomics

Indexed keywords

'VIRGIN'; CYTOKINE; INTERLEUKIN 10; LYPRINOL; MALATE DEHYDROGENASE; NAPROXEN; OLIVE OIL; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; CONTROLLED STUDY; DRUG MECHANISM; DRUG RESPONSE; IMMUNOMODULATION; MALE; NONHUMAN; PAIN ASSESSMENT; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; RAT; REVIEW;

ANIMALIA; PERNA CANALICULUS; RATTUS;

EID: 56049103790     PISSN: 11298723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Gibson RG, Gibson SLM, Conway V, Chappell D. Perna canaliculus in the treatment of arthritis. The Practitioner 1980; 224: 955-60.
2. Rainsford KD, Whitehouse MW. Gastroprotective and anti-inflammatory properties of green-lipped mussel (Perna canaliculus) preparation. Arzneimittelforschung 1980; 30: 2128-32.
3. Speed A, Zwar D. Introducing. The Ocean mussel that packs a punch against arthritis pain. 1997 Bio/Tech News.
4. Whitehouse MW, Macrides TA, Kalafatis N. Anti-inflammatory activity of a lipid fraction (Lyprinol®) from the N. Z. green-lipped mussel. Inflammopharmacology 1997; 5: 237-46.
5. Gibson SLM, Gibson RG. The treatment of arthritis with a lipid extract of Perna canaliculus: a randomized trial. Complementary Therapies in Medicine 1998; 6: 122-6.
6. Halpern G.M. Anti-inflammatory effects of a stabilized lipid extract of Perna canaliculus (Lyprinol®). Allergic and Immunologie (Paris) 2000; 32: 272-8.
7. Shiels IA, Whitehouse MW. Lyprinol®: anti-inflammatory and uterine relaxant activities in rats, with special reference to a model for dysmenorrhea. Allergie and Immunologie (Paris) 2000; 32: 279-83.
8. Cho S H, Jung YB, Seong SC, et al. Clinical efficacy and safety of Lyprinol, a patented extract from New Zealand green-lipped mussel ( Perna canaliculus) in patients with osteoarthritis of the hip and knee: A multicenter 2-month clinical trial. Allergie & Immunologie (Paris) 2003; 35: 212-6.
9. Lau CS, Chiu PKY, Chu EMY, Cheng IYW, Tang WM, Man RYK, Halpern GM. Treatment of knee osteoarthritis with Lyprinol®, lipid extract of the green-lipped mussel -a double-blind placebo-controlled study. Progress in Nutrition 2004; 6: 17-31.
10. Tenikoff D, Murphy KJ, Le M, Butler RN, Howarth GS, Howe PR. Lyprinol™: a potential preventive treatment for inflammatory bowel disease (IBD). Asia Pacific Journal of Clinical Nutrition 2004; 13 Suppl: S94.
11. Halpern GM. The Inflammation Revolution. 2005. Square One Publishers, Garden City, NY, USA.
12. Tenikoff D, Murphy KJ, Le M, Howe PR, Howarth GS. Lyprinol® (stabilized lipid extract of New Zealand green-lipped mussel): a potential preventative treatment modality for inflammatory bowel disease. Journal of Gastroenterology 2005; 40: 361-5.
13. Murphy KJ, Mooney BD, Mann NJ, Nichols PD, Sinclair AJ. Lipid, FA, and sterol composition of New Zealand green-lipped mussel (Perna canaliculus) and Tasmanian blue mussel (Mytilus edulis). Lipids 2002; 37: 587-95.
14. Wolyniak CJ, Brenna T, Murphy KJ, Sinclair AJ. Gas chromatography-chemical ionization-mass spectrometric fatty acid analysis of a commercial supercritical carbon dioxide lipid extract from New Zealand green-lipped mussel (Perna canaliculus). Lipids 2005; 40: 355-60.
15. 4 production by human monocytes. Allergie & Immunologie (Paris) 2000; 32: 284-9.
16. Hooper S. The effect of marine oils on markers of thrombosis in the blood of healthy females. BASc (Hons) Thesis, 1998, RMIT University, Australia.
17. Gruenwald J, Graubaum HJ, Hansen K, Grube B. Efficacy and tolerability of a combination of Lyprinol and high concentrations of EPA and DHA in inflammatory rheumatoid disorders. Advances in Therapy 2004; 21: 197-201.
18. Emelyanov A, Fedoseev G, Krasnoschekova O, Abulimity A, Trendeleva T, Barnes PJ. Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial. European Respiratory Journal 2002; 20: 596-600.
19. Murphy KJ, Mann NJ, Sinclair AJ. Fatty acid and sterol composition of frozen and freeze-dried New Zealand Green Lipped Mussel (Perna canaliculus) from three sites in New Zealand. Asia Pacific Journal of Clinical Nutrition 2003; 12: 50-60.
20. Kang SS, Choi SH. Prophylactic effect of plaster and cataplasm contained ketoprofen in rats with adjuvant arthritis. Journal of Veterinary Science 2001; 20: 65-70.
21. Winder CV, Lembke LA, Stephens MD. Comparative bioassay of drugs in adjuvant-induced arthritis in rats: Flufenamic acid, mefenamic acid, and phenylbutazone. Arthritis & Rheumatism 1969; 12: 472-82.
22. Hayashida K, Kaneko T, Takeuchi T, Shimizu H, Ando K, Harada E. Oral administration of lactoferrin inhibits inflammation and nociception in rat adjuvant-induced arthritis. Journal of Veterinary Medical Science 2004; 66: 149-54.
23. Lee CH, Lum JHK, Ng CKC, McKay J, Butt YKC, Wong MS, Lo SCL. Pain controlling and cytokine-regulating effects of Lyprinol, a lipid extract of Perna canaliculus, in a rat adjuvant-induced arthritis model. eCAM 2007; 1-7 doi:10.1093/ecam/nem100.
24. Lee CH, Butt YKC, Wong MS, Lo SCL. A lipid extract of Perna canaliculus affects the expression of proinflammatory cytokines in a rat adjuvant-induced arthritis model. European Annals of Allergy and Clinical Immunology in press.
25. Lee CH, Butt YKC, Wong MS, Lo SCL. Differential protein expression induced by a lipid extract of Perna canaliculus in splenocytes of rats with adjuvant-induced arthritis. Inflammopharmacology in press.